Sectoral Asset Management as of Dec. 31, 2018
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 104 positions in its portfolio as reported in the December 2018 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 6.6 | $48M | 5.0M | 9.58 | |
Aerie Pharmaceuticals | 5.6 | $41M | 1.1M | 36.10 | |
Alnylam Pharmaceuticals (ALNY) | 4.9 | $36M | 495k | 72.91 | |
Teladoc (TDOC) | 4.3 | $31M | 632k | 49.57 | |
Array BioPharma | 4.2 | $31M | 2.2M | 14.25 | |
Apellis Pharmaceuticals (APLS) | 3.9 | $29M | 2.2M | 13.19 | |
Gilead Sciences (GILD) | 3.6 | $27M | 425k | 62.55 | |
Celgene Corporation | 3.5 | $25M | 397k | 64.09 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.7 | $20M | 1.2M | 17.17 | |
Pfizer (PFE) | 2.5 | $19M | 425k | 43.65 | |
Immunomedics | 2.5 | $19M | 1.3M | 14.27 | |
Novartis (NVS) | 2.5 | $18M | 213k | 85.81 | |
La Jolla Pharmaceuticl Com Par | 2.3 | $17M | 1.8M | 9.43 | |
Portola Pharmaceuticals | 2.2 | $16M | 824k | 19.52 | |
Wright Medical Group Nv | 2.0 | $15M | 535k | 27.22 | |
Ra Pharmaceuticals | 2.0 | $15M | 800k | 18.20 | |
Hill-Rom Holdings | 1.9 | $14M | 160k | 88.55 | |
Bristol Myers Squibb (BMY) | 1.8 | $13M | 257k | 51.98 | |
Cigna Corp (CI) | 1.7 | $13M | 67k | 189.92 | |
Eli Lilly & Co. (LLY) | 1.6 | $12M | 104k | 115.72 | |
Evolent Health (EVH) | 1.6 | $12M | 589k | 19.95 | |
Global Blood Therapeutics In | 1.6 | $12M | 283k | 41.05 | |
UnitedHealth (UNH) | 1.5 | $11M | 44k | 249.12 | |
AtriCure (ATRC) | 1.5 | $11M | 356k | 30.60 | |
Medtronic (MDT) | 1.4 | $11M | 118k | 90.96 | |
Vocera Communications | 1.4 | $10M | 264k | 39.35 | |
Adamas Pharmaceuticals | 1.3 | $9.7M | 1.1M | 8.54 | |
Acceleron Pharma | 1.2 | $9.2M | 212k | 43.55 | |
Boston Scientific Corporation (BSX) | 1.2 | $8.5M | 242k | 35.34 | |
R1 Rcm | 1.2 | $8.5M | 1.1M | 7.95 | |
EXACT Sciences Corporation (EXAS) | 1.1 | $8.5M | 134k | 63.10 | |
Intec Pharma | 1.1 | $8.3M | 1.1M | 7.54 | |
Ptc Therapeutics I (PTCT) | 1.1 | $8.0M | 234k | 34.32 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $7.8M | 92k | 85.16 | |
Tandem Diabetes Care (TNDM) | 1.1 | $7.7M | 203k | 37.97 | |
Insulet Corporation (PODD) | 1.0 | $7.6M | 96k | 79.32 | |
Abiomed | 1.0 | $7.3M | 22k | 325.05 | |
Viewray (VRAYQ) | 1.0 | $7.3M | 1.2M | 6.07 | |
Obseva Sa | 1.0 | $7.1M | 565k | 12.66 | |
Abbott Laboratories (ABT) | 1.0 | $7.1M | 98k | 72.33 | |
Irhythm Technologies (IRTC) | 0.9 | $6.8M | 97k | 69.48 | |
Savara (SVRA) | 0.9 | $6.4M | 847k | 7.57 | |
Seattle Genetics | 0.9 | $6.3M | 112k | 56.66 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $6.0M | 36k | 165.72 | |
Albireo Pharma | 0.8 | $5.6M | 230k | 24.53 | |
Biogen Idec (BIIB) | 0.8 | $5.5M | 18k | 300.91 | |
Unum Therapeutics Ord | 0.8 | $5.5M | 1.3M | 4.40 | |
Evelo Biosciences | 0.7 | $5.3M | 407k | 13.01 | |
Proteostasis Therapeutics In | 0.7 | $5.1M | 1.6M | 3.24 | |
WellCare Health Plans | 0.6 | $4.6M | 19k | 236.09 | |
Meiragtx Holdings (MGTX) | 0.5 | $3.9M | 408k | 9.64 | |
Sage Therapeutics (SAGE) | 0.5 | $3.6M | 37k | 95.80 | |
Assembly Biosciences | 0.5 | $3.6M | 157k | 22.62 | |
Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.2M | 29k | 112.72 | |
Cardiovascular Systems | 0.4 | $2.9M | 101k | 28.49 | |
Nightstar Therapeutics | 0.4 | $2.7M | 234k | 11.52 | |
Spring Bk Pharmaceuticals In | 0.4 | $2.6M | 252k | 10.39 | |
Johnson & Johnson (JNJ) | 0.3 | $2.3M | 18k | 129.05 | |
Beigene | 0.3 | $2.1M | 15k | 140.28 | |
Molecular Templates | 0.2 | $1.4M | 350k | 4.04 | |
Alder Biopharmaceuticals | 0.2 | $1.3M | 128k | 10.25 | |
Thermo Fisher Scientific (TMO) | 0.1 | $1.0M | 4.5k | 223.79 | |
Anthem (ELV) | 0.1 | $883k | 3.4k | 262.72 | |
Hutchison China Meditech (HCM) | 0.1 | $730k | 32k | 23.08 | |
Becton, Dickinson and (BDX) | 0.1 | $679k | 3.0k | 225.21 | |
Dr. Reddy's Laboratories (RDY) | 0.1 | $682k | 18k | 37.69 | |
ImmunoGen | 0.1 | $650k | 135k | 4.80 | |
Hca Holdings (HCA) | 0.1 | $662k | 5.3k | 124.53 | |
Humana (HUM) | 0.1 | $526k | 1.8k | 286.49 | |
Universal Health Services (UHS) | 0.1 | $338k | 2.9k | 116.71 | |
HMS Holdings | 0.1 | $349k | 12k | 28.15 | |
D Stemline Therapeutics | 0.1 | $369k | 39k | 9.50 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $393k | 9.0k | 43.44 | |
Kalvista Pharmaceuticals (KALV) | 0.1 | $347k | 18k | 19.77 | |
Sierra Oncology | 0.1 | $343k | 202k | 1.70 | |
Stryker Corporation (SYK) | 0.0 | $324k | 2.1k | 156.82 | |
Cerus Corporation (CERS) | 0.0 | $307k | 61k | 5.07 | |
Dermira | 0.0 | $301k | 42k | 7.18 | |
Zai Lab (ZLAB) | 0.0 | $292k | 13k | 23.19 | |
Zimmer Holdings (ZBH) | 0.0 | $218k | 2.1k | 103.86 | |
Centene Corporation (CNC) | 0.0 | $240k | 2.1k | 115.38 | |
Chemocentryx | 0.0 | $194k | 18k | 10.89 | |
Revance Therapeutics (RVNC) | 0.0 | $226k | 11k | 20.12 | |
Ikang Healthcare Group- | 0.0 | $235k | 12k | 20.41 | |
Coherus Biosciences (CHRS) | 0.0 | $253k | 28k | 9.04 | |
Blueprint Medicines (BPMC) | 0.0 | $226k | 4.2k | 54.02 | |
Antares Pharma | 0.0 | $129k | 47k | 2.73 | |
Acelrx Pharmaceuticals | 0.0 | $170k | 74k | 2.30 | |
Mei Pharma | 0.0 | $118k | 45k | 2.65 | |
Cytomx Therapeutics (CTMX) | 0.0 | $152k | 10k | 15.11 | |
Kura Oncology (KURA) | 0.0 | $166k | 12k | 14.07 | |
Biolinerx Ltd-spons | 0.0 | $87k | 198k | 0.44 | |
Tetraphase Pharmaceuticals | 0.0 | $45k | 40k | 1.13 | |
Cytokinetics (CYTK) | 0.0 | $98k | 16k | 6.29 | |
Quotient | 0.0 | $108k | 18k | 6.12 | |
Marinus Pharmaceuticals | 0.0 | $48k | 17k | 2.86 | |
Abeona Therapeutics | 0.0 | $91k | 13k | 7.18 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $60k | 25k | 2.36 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $46k | 13k | 3.65 | |
Aeglea Biotherapeutics | 0.0 | $97k | 13k | 7.49 | |
Protagonist Therapeutics (PTGX) | 0.0 | $77k | 11k | 6.75 | |
Nabriva Therapeutics | 0.0 | $56k | 38k | 1.46 | |
Protalix BioTherapeutics | 0.0 | $31k | 100k | 0.31 | |
Clearside Biomedical (CLSD) | 0.0 | $28k | 26k | 1.08 |